Rob Robertson, Mba Email & Phone Number

Newtown, PA, US

Springfield, New Jersey, US

Hatboro, Pennsylvania, US

Express is a PE-Backed transportation asset management enterprise comprising one of the largest 4x4 truck fleets in the United States. - Headed capital budget and successfully grew revenues 60%. Grew assets 100% by establishing a Strategic Alliance with a major OEM.

Lan Pac comprises a 75,000 square foot manufacturing facility producing 1.5M square feet of corrugated packaging (boxes) per year.  Led company M&A process which led to the sale of Lan Pac at 6x EBITDA and grew revenues by 32% from 2017 to 2019 by signing a Strategic Alliance with a 3rd party corrugated enterprise. Implemented new financial reporting.

Basel, Baselstadt, CH

Novartis is a Swiss multinational pharmaceutical corporation with revenues of ~$48B in 2016. Over 12-year career at Novartis, led / participated in transactions that created ~ $10BN in shareholder value.  Rolled out innovative products at Novartis including Cosentyx (autoimmune medicine) with annual revenue streams of $4B+. Led / Participated in key.

Basel, Baselstadt, CH

Served as Finance lead on all US Pharmaceutical strategic option decisions. Conducted financial valuation in support of US Licensing Deals including in-licensing, out-licensing, divestitures, co-promotions, and acquisitions. Developed dynamic valuation models that incorporated risk and multiple scenarios options; and effectively negotiating team to.

Basel, Baselstadt, CH

Served as Head of Finance on all Global Vaccines & Diagnostics strategic option decisions. Lead a team of three that conducted financial valuation and due diligence in support of US Licensing Deals including in-licensing, out-licensing, divestitures, co-promotions, and acquisitions. Was co-chair of Deal Review Committee which presented opportunities to.

Basel, Baselstadt, CH

Served as Finance lead on Global Pharmaceutical strategic option decisions. Conducted financial valuation in support of Global Licensing Deals including in-licensing, out-licensing, divestitures, co-promotions, and acquisitions. Developed dynamic valuation models that incorporated risk and multiple scenarios options; and effectively negotiating team to.

 Conducted financial analysis to facilitate U.S. Human Health strategic business initiatives.  Integral in supporting Business Development and Merck Capital Ventures in designing and evaluating internal and external business opportunities, including acquisitions, licensing co-promotions, and divestitures.

 Served as primary financial support person for the Dermatology, Urology, Ophthalmology, Anti-Ulcercant Franchises, and the Specialty Sales Force while providing leadership and supervision to two senior financial institutions Analysts.  Partnered with F.B.G.s and Marketing Services to design annual Profit Plan, interim forecasts, and Long-Range Operating.

Drafted and evaluated monthly results for U.S. Human Health sales and product costs, developed annual Profit Plan, interim forecasts, and Long-Range Operating Plan for U.S. Human Health sales and product cost.  Co-Launched Go-To-Market Strategy for Propecia (male pattern baldness medication) at Merck which generated ~$5.2B in revenue from 1999 – 2015.

Bachelor Of Science - Bs, Accounting, Finance, And Applied Mathematics

Master Of Business Administration - Mba, Finance And Marketing